Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease

AM Conge, K Tarte, J Reynes, M Segondy, J Gerfaux… - Aids, 1998 - journals.lww.com
AM Conge, K Tarte, J Reynes, M Segondy, J Gerfaux, M Zembala, JP Vendrell
Aids, 1998journals.lww.com
Objective: This study was performed to investigate the hyporeactivity of purified B
lymphocytes from HIV-1-infected patients. Design: Given the importance of the B-cell Ag
receptor (BCR) and CD40 in B-lymphocyte activation, we assessed the capacity of purified
peripheral blood B lymphocytes from HIV-1-infected patients to differentiate into Ig-secreting
cells in a T-cell-and accessory-cell-independent system of BCR and CD40 costimulation.
Methods: B lymphocytes from 21 HIV-1-infected patients were purified by immunomagnetic …
Abstract
Objective:
This study was performed to investigate the hyporeactivity of purified B lymphocytes from HIV-1-infected patients.
Design:
Given the importance of the B-cell Ag receptor (BCR) and CD40 in B-lymphocyte activation, we assessed the capacity of purified peripheral blood B lymphocytes from HIV-1-infected patients to differentiate into Ig-secreting cells in a T-cell-and accessory-cell-independent system of BCR and CD40 costimulation.
Methods:
B lymphocytes from 21 HIV-1-infected patients were purified by immunomagnetic cell separation and costimulated with immobilized anti-CD40 monoclonal antibodies and Staphylococcus aureus Cowan I particles in the presence of interleukin (IL)-2 and IL-10. Homotypic aggregate formation, apoptosis, cell cycle entrance, proliferation and Ig secretion of B cells were analysed.
Results:
Costimulation by the BCR and CD40 induced proliferation and differentiation of B lymphocytes into Ig-secreting cells in 13 patients (group I) but not in eight patients (group II). For three patients in group II, the dual triggering induced apoptosis of B cells. The unexpected inability of these cells to differentiate was associated with a high CD38 expression and a weak spontaneous production of Ig or anti-HIV-1 antibodies in patients with a high viral load and a low CD4+ lymphocyte count. Despite this anomaly, the B cells from group II were able to progress through the cell cycle after stimulation with a combination of phorbol ester and ionomycin in complete medium, suggesting an impairment in BCR and CD40 early signal transduction.
Conclusion:
Intrinsic in vitro hyporeactivity of B lymphocytes to dual triggering of BCR and CD40 was observed in advanced HIV-1 disease and appeared to be related to in vivo hyperactivation of B cells.
Lippincott Williams & Wilkins